Treatment for anal cancer depends on various factors, including the type, size, location, and stage of the tumour, as well as the patient’s overall health. Common treatment options include:
The most common type of anal cancer is squamous cell carcinoma, which arises from the squamous cells lining the anal canal below the anal verge.
Less frequent type of anal cancer is adenocarcinoma, arising from glandular cells above the anal verge.
Other uncommon types include basaloid carcinoma, melanoma, lymphoma, and sarcoma. Each type has unique characteristics and may require different treatment strategies.
Symptoms of anal cancer can be subtle initially but may become more pronounced as the disease progresses. Common signs and symptoms include:
Several factors can increase the risk of developing anal cancer, including:
Treatment for anal cancer depends on various factors, including the type, size, location, and stage of the tumour, as well as the patient’s overall health. Common treatment options include:
The standard treatment for squamous cell carcinoma, combining chemotherapy and radiation to shrink the tumour and destroy cancer cells.
Includes pain management, nutritional support, and psychological support to improve quality of life, especially in advanced stages.
Used for specific cases, such as when the cancer does not respond to chemoradiation or if it recurs. Procedures range from local excision to more extensive surgeries like abdominoperineal resection (APR) for advanced cases.
Emerging treatments, particularly for advanced or metastatic cases. Immunotherapy helps the immune system target cancer cells, while targeted therapy focuses on specific molecular abnormalities in the cancer.
Brachytherapy involves placing a radioactive source directly into or near the tumour. However, brachytherapy is less commonly used for anal cancer compared to other cancers like cervical or prostate cancer.
Proton Beam Therapy is an advanced form of radiotherapy that uses protons instead of x-rays. Proton beam therapy is especially beneficial for tumours located near critical structures, but its availability is limited and may not be widely used for anal cancer.
Stereotactic Body Radiation Therapy (SBRT), also known as stereotactic ablative radiotherapy (SABR), delivers very high doses of radiation with extreme precision over a few sessions. While SBRT is more commonly used for small, well-defined tumours in other parts of the body, its role in anal cancer is limited and typically reserved for certain cases, such as recurrent disease or metastases.
In most cases, radiotherapy for anal cancer is combined with chemotherapy (chemoradiation), which enhances the sensitivity of cancer cells to radiation and increases the effectiveness of the treatment. The choice of radiotherapy technique depends on various factors, including the tumour’s size, location, stage, and the patient’s overall health. The treatment plan is tailored to each patient’s needs, aiming to maximise tumour control while minimising side effects.
